Real-World Study on the Impact of Atopic Dermatitis From a Caregiver Perspective

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-01-31

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will address this gap by providing comprehensive data on disease burden from a caregiver perspective in a Canadian population, ultimately supporting improved clinical decision-making and healthcare resource allocation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Observational Evaluation of Atopic Dermatitis in Pediatric Patients

NCT03687359

Dermatitis Atopic

ACTIVE_NOT_RECRUITING

Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis

NCT05990725

Atopic Dermatitis Eczema

ACTIVE_NOT_RECRUITING PHASE3

Eczema Action Plan Improves Patient and Caregiver Understanding and Perception of Atopic Dermatitis Management

NCT01660217

Atopic Dermatitis

COMPLETED NA

Collection of Clinical and Instrumental Data in Adult Subjects Suffering From Atopic Dermatitis

NCT04553224

Atopic Dermatitis

COMPLETED NA

Short-term Topical Application to Prevent Atopic Dermatitis

NCT03871998

Eczema Atopic Dermatitis Eczema Eczema, Infantile +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atopic Dermatitis Eczema Atopic Dermatitis Eczema Caregiver Burden

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Caregiver of child with atopic dermatitis

Caregiver of a child aged ≥2 to ≤11 years with mild to moderate AD

No Intervention: Observational Cohort

Intervention Type OTHER

No specific intervention is assess in this study. Observational cohort.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No Intervention: Observational Cohort

No specific intervention is assess in this study. Observational cohort.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Aged ≥18 years;
2. Caregiver of a child aged ≥2 to ≤11 years with mild to moderate AD;
3. Able to read and understand French or English;
4. Willing and able to provide written informed consent.

Exclusion Criteria

1. Caregivers whose child has been diagnosed with severe AD ;
2. Caregivers whose child is currently treated with oral or topical JAK inhibitor);
3. Caregivers whose child is currently participating in a clinical trial for AD;
4. Other parent or caregiver within the household of the child with AD.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes